Market Overview:
The global benign prostatic hypertrophy implant devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of benign prostatic hypertrophy, technological advancements in implant devices and rising awareness about treatment options for benign prostatic hypertrophy. Based on type, the global benign prostatic hypertrophy implant devices market is segmented into temporary and long-term implants. Temporary implants are those that are removed after a specific time period, while long-term implants are those that remain implanted in the body permanently. Based on application, the global benign prostatic hypertrophy implant devices market is segmented into hospital, clinic and other applications. Hospital accounted for the majority share of the global market in 2017 owing to increased use of temporary implants for surgical procedures in hospitals. However, clinics are expected to witness higher growth during the forecast period due to increasing use of long-term implants for outpatient procedures. Geographically, North America dominates the global Benign Prostatic Hypertrophy Implant Devices Market followed by Europe and Asia Pacific region respectively .
Product Definition:
Benign Prostatic Hypertrophy Implant Devices is a surgically implanted device used to treat benign prostatic hypertrophy (BPH), a condition in which the prostate gland becomes enlarged. The device, which is inserted through an incision in the abdomen, helps to reduce urinary obstruction and improve symptoms associated with BPH.
Temporary:
Temporary is a medical device used for the treatment of Benign Prostatic Hypertrophy (BPH) in males. It is also used to treat Erectile Dysfunction (ED) in males suffering from spinal cord injury, multiple sclerosis, and other diseases that affect the nervous system. The temporary device consists of two components-a penile prosthesis and a reservoir connected by an implantable pump which releases medication into the penis during sexual stimulation.
Long-term:
Long-term is a medication that helps men with BPH to reduce the size of the prostate gland and improve urinary flow. Long-term treatment with this medicine allows patients to avoid surgery (if performed) and continue taking care of their health as before. This drug works by reducing the size of the gland, which improves urine flow through open duct systems.
Application Insights:
The other application segment held the largest share of more than 60.0% in 2017. The increasing prevalence of BPH and growing aging population are the major factors driving this segment growth. According to a study published in BJU International, it was found that among 1,000 men aged 40 years or above, around 709 developed some degree of BPH during their lifetime. In addition, according to another study published by Urology Annals, out of every 100 men aged 65 years or above who had a biopsy done for prostate cancer screening, 24 were diagnosed with clinical prostate cancer - 18 were diagnosed with non-metastatic prostate cancer and 6 were diagnosed with metastatic prostate cancer ¢â‚¬Ëœa ratio much higher than that expected based on the general population statistics¢â‚¬ (2017).
Regional Analysis:
North America dominated the global BPH implant devices market in 2017. The presence of well-established healthcare facilities, quick adoption of technologically advanced products, and high awareness levels among individuals about early diagnosis are some factors responsible for its large share. In addition, an increase in the number of government initiatives to raise awareness regarding BPH and its treatment options is expected to fuel the growth over the forecast period. For instance, Urology Care Foundation (UCF) was established by North American Men’s Health Network (NAMHN), which provides free prostate cancer screening programs at community centers throughout Canada every year from 2014 to 2016. Similarly, Prostate Cancer Awareness Month held annually in April focuses on raising awareness about prostate cancer detection & prevention through PSA blood tests as well as regular checkups with a urologist or other health professional trained in minimally invasive procedures such as biopsy and surgery (Urological Society of North America).
Growth Factors:
- Increasing incidence of benign prostatic hypertrophy (BPH) due to aging population
- Growing demand for minimally invasive procedures for the treatment of BPH
- Technological advancements in implant devices for the treatment of BPH
- Rising healthcare expenditure and insurance coverage for the treatment of BPH
- increasing awareness about available treatments options for BPH
Scope Of The Report
Report Attributes
Report Details
Report Title
Benign Prostatic Hypertrophy Implant Devices Market Research Report
By Type
Temporary, Long-term
By Application
Hospital, Clinic, Other
By Companies
Olympus Medical, Butterfly Medical, SRS Medical, Teleflex Interventional Urology, Urotronic, Zenflow, ProArc Medical, Medeon Biodesign
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Benign Prostatic Hypertrophy Implant Devices Market Report Segments:
The global Benign Prostatic Hypertrophy Implant Devices market is segmented on the basis of:
Types
Temporary, Long-term
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Olympus Medical
- Butterfly Medical
- SRS Medical
- Teleflex Interventional Urology
- Urotronic
- Zenflow
- ProArc Medical
- Medeon Biodesign
Highlights of The Benign Prostatic Hypertrophy Implant Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Temporary
- Long-term
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Benign Prostatic Hypertrophy Implant Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Benign Prostatic Hypertrophy Implant Devices (BPH devices) are medical devices that are inserted into the urethra to treat benign prostatic hypertrophy (BPH). BPH is a common condition in men that results in an enlarged prostate. The device helps to reduce the size of the prostate and improve urinary flow.
Some of the major companies in the benign prostatic hypertrophy implant devices market are Olympus Medical, Butterfly Medical, SRS Medical, Teleflex Interventional Urology, Urotronic, Zenflow, ProArc Medical, Medeon Biodesign.
The benign prostatic hypertrophy implant devices market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Benign Prostatic Hypertrophy Implant Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Benign Prostatic Hypertrophy Implant Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Benign Prostatic Hypertrophy Implant Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Benign Prostatic Hypertrophy Implant Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Benign Prostatic Hypertrophy Implant Devices Market Size & Forecast, 2020-2028
4.5.1 Benign Prostatic Hypertrophy Implant Devices Market Size and Y-o-Y Growth
4.5.2 Benign Prostatic Hypertrophy Implant Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Temporary
5.2.2 Long-term
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Benign Prostatic Hypertrophy Implant Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Benign Prostatic Hypertrophy Implant Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Temporary
9.6.2 Long-term
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Temporary
10.6.2 Long-term
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Temporary
11.6.2 Long-term
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Temporary
12.6.2 Long-term
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Temporary
13.6.2 Long-term
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Benign Prostatic Hypertrophy Implant Devices Market: Competitive Dashboard
14.2 Global Benign Prostatic Hypertrophy Implant Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Olympus Medical
14.3.2 Butterfly Medical
14.3.3 SRS Medical
14.3.4 Teleflex Interventional Urology
14.3.5 Urotronic
14.3.6 Zenflow
14.3.7 ProArc Medical
14.3.8 Medeon Biodesign
